ThyroSeq:

Sam Sirotnikov1, Christopher C Griffith2, Daniel Lubin1

  • 1Department of Pathology, Emory University, Atlanta, Georgia, USA.

PubMed
概括

ThyroSeq v3 准确地评估了在不确定的甲状腺结节中恶性瘤的风险. 这种分子测试有助于指导手术决策,改善了对甲状腺癌患者的治疗.